drugset / Trial / NCT01136525

Bioavailability Study of Valacyclovir HCl Tablets, 1000 mg of Dr. Reddy's Under Fasting Conditions

NCT01136525

Phase 1 Completed 41 enrolled Dr. Reddy's Laboratories Limited
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to 1. Compare and evaluate the single-dose bioavailability study of 1000mg Valacyclovir HCl tablets of Dr. Reddy's and Valtrex (R)(Valacyclovir Hydrochloride)CAPLETS 1 gram of GlaxoSmithkline, in healthy, adult human subjects under fasting conditions. 2. monitor the adverse events and ensure the safety of subjects.

Timeline

Start
2007-02
Primary completion
2007-03
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Valacyclovir Unknown 1000 mg

Indications

No indication recorded.